Market Overview

Buckingham Research Downgrades Teva Pharmaceutical Industries Limited to Neutral, Removes $56 P

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for TEVA

DateFirmActionFromTo
Apr 2015Standpoint ResearchUpgradesHoldBuy
Apr 2015Argus ResearchMaintainsBuy
Apr 2015BMO CapitalDowngradesOutperformMarket Perform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (TEVA)

Around the Web, We're Loving...